María Cristina Ballesteros-Briones

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming

Alfonso R. Sánchez-Paulete, Álvaro Teijeira, José I. Quetglas et al. · Cancer Research · 2018 · 87 citations · Full text

Medicine, Immunology, Oncology +17

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

María Cristina Ballesteros-Briones, Eva Martišová, Erkuden Casales et al. · Molecular Therapy · 2019 · 41 citations · Full text

Pharmacy, Immunology, Oncology +17

Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane

Marta Ruiz-Guillen, Evgeni Evgeniev Gabev, José I. Quetglas et al. · Cellular and Molecular Life Sciences · 2016 · 28 citations · Full text

Life Sciences, Microbiology, Molecular Biology +16

Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity

Noelia Silva-Pilipich, Eva Martišová, María Cristina Ballesteros-Briones et al. · Biomedicines · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

Noelia Silva-Pilipich, Ester Blanco, Teresa Lozano et al. · Cancer Letters · 2023 · 18 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17